Viatris rises as it teams up with GoodRx to offer discounts on brand‑name drugs

Viatris

11/03/2026 15:01

** Shares of Viagra and Xanax maker Viatris VTRS.O rise 1.1% to $14.24

** Co says it partnered with GoodRx GDRX.O to offer discounts of up to 85% on 17 established drugs, including Lipitor, Celebrex, Viagra and Norvasc

** Co says eligible commercially insured patients can pay $0–$4 for select drugs; cash‑paying customers can access discounted prices at 70,000+ U.S. pharmacies

** VTRS says the program aims to improve access to widely used medicines by reducing cost barriers

** GoodRx says it has similar savings programs with other drugmakers for drugs such as Ozempic, Humira biosimilars and Lantus

** Shares were flat in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))